A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-Group Study of Bifeprunox in the Treatment of Depression in Outpatients With Bipolar Disorder.
Phase of Trial: Phase III
Latest Information Update: 14 Feb 2013
At a glance
- Drugs Bifeprunox (Primary)
- Indications Bipolar disorders
- Focus Registrational; Therapeutic Use
- Sponsors Wyeth
- 14 Feb 2013 Actual end date May 2006 added as reported by ClinicalTrials.gov.
- 14 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Sep 2006 New trial record.